Lung mass evaluation: Difference between revisions

Jump to navigation Jump to search
Maria Villarreal (talk | contribs)
No edit summary
Maria Villarreal (talk | contribs)
No edit summary
Line 6: Line 6:


A hallmark feature in the evaluation of lung mass is the malignancy assessment. The evaluation approach of lung mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of lung mass. Lung mass can be divided into 2 categories: benign pulmonary mass and malignant lung mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.
A hallmark feature in the evaluation of lung mass is the malignancy assessment. The evaluation approach of lung mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of lung mass. Lung mass can be divided into 2 categories: benign pulmonary mass and malignant lung mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.


==Lung Mass Evaluation==
==Lung Mass Evaluation==
*The algorithm below summarizes the initial lung mass evaluation according to imaging features, location, and distribution.  
*The algorithm below summarizes the initial lung mass evaluation according to imaging features, location, and distribution.  



Revision as of 17:54, 22 March 2016

Lung Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Lung Mass from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Diagnosis

Diagnostic Study of Choice

Evaluation of Lung Mass

Imaging of Lung Mass

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Lung mass evaluation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung mass evaluation

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung mass evaluation

CDC on Lung mass evaluation

Lung mass evaluation in the news

Blogs on Lung mass evaluation

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Lung mass evaluation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

A hallmark feature in the evaluation of lung mass is the malignancy assessment. The evaluation approach of lung mass will mainly depend in the initial morphological evaluation of the mass (size, margins, contours, and growth). Other characteristics, such as: location, clinical features, and distribution may be helpful for the therapeutical management, surveillance, and follow-up of lung mass. Lung mass can be divided into 2 categories: benign pulmonary mass and malignant lung mass. Based upon these categories, complementary diagnostic studies and management, include: PET/CT scan, CT scan, non-surgical biopsy, and surgical resection.

Lung Mass Evaluation

  • The algorithm below summarizes the initial lung mass evaluation according to imaging features, location, and distribution.


References